在卵巢癌患者中,关于化疗诱导的骨髓抑制的知识,态度和实践
1Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, China.
World journal of surgical oncology
|September 30, 2025
概括
卵巢癌患者表现出足够的知识和实践,但对化疗诱导的骨髓抑制的态度和健康素养不佳. 建议针对性的教育和行为干预措施,以改善管理.
科学领域:
- 在瘤学瘤学.
- 患者护理 患者护理
- 卫生识字 卫生识字
背景情况:
- 调查卵巢癌患者关于化疗诱导的骨髓抑制的知识,态度和实践 (KAP).
- 了解患者的观点对于有效管理治疗副作用至关重要.
研究的目的:
- 评估卵巢癌患者关于化疗诱导的骨髓抑制的KAP.
- 确定影响这些KAP的因素,并为干预策略提供信息.
主要方法:
- 一项涉及505名卵巢癌患者的横截面研究.
- 使用自主设计的问卷来评估KAP和健康素养收集的数据.
- 统计分析包括相关性和多变量逻辑回归,结构方程建模 (SEM).
主要成果:
- 患者表现出足够的知识 (平均得分为20.69/18),适度的态度 (34.69/50),积极的做法 (34.30/45),和健康素养差 (8.18/15).
- 在KAP组件之间发现了正相关性,而KAP与健康素养之间显示了负相关性.
- 知识,态度,教育和癌症阶段对实践产生了积极的影响,而年龄较大与较低的实践成绩有关.
结论:
- 卵巢癌患者在化疗诱导的骨髓抑制方面存在知识与实践上的差距,健康素养低下加剧了这一问题.
- 教育和行为干预对于提高患者对骨髓抑制的理解和自我管理至关重要.
- 未来的研究应该专注于开发和评估有针对性的干预措施,以改善患者的治疗结果.
相关概念视频
Nursing Ethical Principles II
2.1K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.1K
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
602
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
602
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
588
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
588
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

